Letters
Multidisciplinary cancer teams
Crucial for population health
BMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c2125 (Published 20 April 2010) Cite this as: BMJ 2010;340:c2125
- Fiona Day, consultant in public health1,
- Colin Pollock,
- Caroline Brook,
- Alex Albus
- 1NHS Yorkshire and the Humber
- fiona.day{at}yorkshireandhumber.nhs.uk
Although formal evidence on the cost benefits of clinical decision making by multidisciplinary teams in cancer may be lacking,1 the Cancer Reform Strategy identifies such team meetings as important for collecting and validating clinical cancer data, particularly comorbidities, performance status, and …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.